Day: June 7, 2022
Minim
Courtesy of Minim, Inc.Motorola MT8733 DOCSIS 3.1 Modem/Router with motosync App Offers Xfinity Customers Savings on Modem Rental Fees and Secure, Fast WiFi
MANCHESTER, NH, June 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Minim, Inc. (NASDAQ: MINM), the creator of intelligent WiFi software and Motorola home networking products under an exclusive global brand license, announces a retail shelf expansion with its first WiFi 6 Modem/Router product placement in hundreds of Best Buy locations across the United States. The Motorola MT8733 DOCSIS 3.1 Cable Modem comes with a powerful, built-in 4×4 AX6000 router; the motosync app, powered by Minim; and two phone lines for Xfinity Voice support. For the first time, Best Buy shoppers with Gigabit speed broadband plans and Xfinity Voice have the option to purchase their own...
SeaStar Medical Announces Publication of Clinical Trial Results Demonstrating its SCD Significantly Lowered Mortality Rates among Critically Ill ICU COVID-19 Patients by Safely and Effectively Stopping Inflammation Causing Cytokine Storms
Written by Customer Service on . Posted in Public Companies.
Results published in the Society of Critical Care Management’s journal, Critical Care Explorations
DENVER, CO and TAMPA, FL, June 07, 2022 (GLOBE NEWSWIRE) — SeaStar Medical, a medical technology company developing a platform therapy to reduce the consequences of hyperinflammation on vital organs, and LMF Acquisition Opportunities, Inc. (NASDAQ: LMAO) (LMAO), a special purpose acquisition company, today announced the publication of results from SeaStar Medical’s pilot SCD 005 clinical study to evaluate the safety and clinical outcomes of extracorporeal immunomodulation treatment with SeaStar Medical’s Selective Cytopheretic Device (SCD) in COVID-19 patients with multiple organ failure in the intensive care unit (ICU). The article, “Extracorporeal Immunomodulation Treatment and Clinical Outcomes in ICU COVID-19 Patients,”...
Maison Luxe Provides Update on Investment Holding Aether Diamonds, Producer of World’s Only Carbon-Negative Diamonds
Written by Customer Service on . Posted in Public Companies.
Aether Named Top Ten Most Innovative Consumer Goods Companies in 2022 by Fast Company
FORT LEE, NJ, June 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Maison Luxe, Inc. (OTC: MASN) (“Maison Luxe” or the “Company”), an emerging leader in the global custom luxury goods marketplace, is pleased to update shareholders on the Company’s investment holding, Impossible Diamond, Inc, d/b/a Aether Diamonds (“Aether”), the first and only carbon-negative diamond producer in the world.
Maison Luxe has participated in two rounds as an early-stage investor in Aether.
Aether creates beautiful gemstone-quality precious diamonds entirely from capturing damaging excess CO2 from the Earth’s atmosphere through its unique IP-protected production process. Aether recently put out an update to its shareholders noting a number of positive strides,...
Longboard Pharmaceuticals to Present at the JMP Securities 2022 Life Sciences Conference on June 15
Written by Customer Service on . Posted in Public Companies.
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) — Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that Kevin Lind, Longboard’s President & CEO, will present at the JMP Securities Life Sciences Conference on June 15, 2022, at 3:00PM ET, in New York City.
To access a webcast of the presentation, please visit the “Events & Presentations” page within the Investors Relations section of Longboard’s website at https://www.longboardpharma.com/. The presentation will be archived on the website for at least 30 days following the event.
About Longboard Pharmaceuticals Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines...
Palisade Bio to Present at the 2022 BIO International Convention
Written by Customer Service on . Posted in Public Companies.
In-person presentation on Monday, June 13th at 1:45 PM PT
CARLSBAD, Calif., June 07, 2022 (GLOBE NEWSWIRE) — Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that Tom Hallam, Ph.D., Chief Executive Officer of Palisade Bio, will present on Monday, June 13, 2022 at 1:45 PM PT at the 2022 BIO International Convention being held in San Diego, CA.
In addition to the presentation, management will be available to participate in one-on-one meetings with industry executives and qualified members of the investor community who are registered to attend the conference. To schedule a meeting with the Company, please reach out through the BIO partnering system.
For more information, please visit the conference website.
About BIOBIO...
Founder Julie Wainwright to Step Down as CEO, Chairperson and Director of The RealReal
Written by Customer Service on . Posted in Public Companies.
Rati Sahi Levesque and Robert Julian Appointed Co-Interim Chief Executive Officers of the Company
SAN FRANCISCO, June 07, 2022 (GLOBE NEWSWIRE) — The RealReal (the “Company” or “The RealReal”) (Nasdaq: REAL)—the world’s largest online marketplace for authenticated, resale luxury goods—today announced that after 11 years of leadership, its Founder Julie Wainwright has decided to step down from her role as Chief Executive Officer (“CEO”), Chairperson and member of the board of directors (the “Board”) of the Company, effective June 7, 2022. As part of the transition, the Board has appointed Rati Sahi Levesque, the Company’s President and Chief Operating Officer, and Robert Julian, the Company’s Chief Financial Officer, as Co-Interim Chief Executive Officers, effective June 7, 2022.
The Board will retain an executive search firm to...
Clearmind Medicine Announces Positive Pre-Clinical Results for Cocaine Addiction Treatment
Written by Customer Service on . Posted in Public Companies.
The dedicated treatment demonstrated a significant decrease in preference for an area associated with cocaineVANCOUVER, June 07, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND), (OTC Pink: CMNDF), (FSE: CWY0) (“Clearmind” or the “company“), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced positive pre-clinical results for its treatment for cocaine addiction using MEAI, its novel psychedelic molecule.“This exciting research on MEAI could go a long way in helping those who need it,” said Dr. Adi Zuloff-Shani, Clearmind’s Chief Executive Officer. “While effective treatments for opioid addictions have been available, this could be the first dedicated treatment for cocaine addiction,...
Tactical Resources Provides Corporate Update
Written by Customer Service on . Posted in Public Companies.
Figure 1a Sierra Blanca Quarry, Texas
Figure 1a Sierra Blanca Quarry, TexasFigure 1b Sierra Blanca Quarry, Texas
Figure 1b Sierra Blanca Quarry, TexasVANCOUVER, British Columbia, June 07, 2022 (GLOBE NEWSWIRE) — Tactical Resources Corp. (CSE: RARE) (“Tactical Resources” or the “Company”), a mineral exploration and development company focused on the rare earth elements (REE) that drive the green technologies of the future, is pleased to provide an update regarding sector outlook and an overview of corporate activities.
As noted by numerous media outlets, as well as a recent Tactical Resources’ news release of April 7, 2022, the significance of the Biden administration’s invocation of the Defense Production Act is of increasing importance as the growing threat of military aggression continues to cause considerable concern regarding...
Acer Therapeutics Issues Statement Regarding PDUFA Target Action Date for ACER-001
Written by Customer Service on . Posted in Public Companies.
NEWTON, Mass., June 07, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that it has not yet received a decision from the U.S. Food and Drug Administration (FDA) on its 505(b)(2) New Drug Application (NDA) for ACER-001 (sodium phenylbutyrate) for the treatment of urea cycle disorders (UCDs). The NDA for ACER-001 for UCDs was accepted for review by FDA on October 5, 2021 at which time FDA assigned a PDUFA target action date of Sunday, June 5, 2022. FDA has informed Acer that review for ACER-001 is ongoing and the agency currently does not have a set target date. Under the Prescription Drug User Fee Act (PDUFA), FDA’s review...
SFLMaven Announces Robust Week Powering $286k in Sales for Seven Days Ended June 2
Written by Customer Service on . Posted in Public Companies.
SFLMaven Announces Robust Week Powering $286k in Sales for Seven Days Ended June 2
Heavy 18K WG 28.64CT diamond sapphire tourmaline pearl formal necklace. Sold for $7,988 at last week’s SFLMaven Famous Thursday Night AuctionSFLMaven Announces Robust Week Powering $286k in Sales for Seven Days Ended June 2
Vintage heavy 14K/Platinum 5.0CT diamond and sapphire filigree cuff bracelet. Sold for $4,549FORT LAUDERDALE, FL, June 07, 2022 (GLOBE NEWSWIRE) — SFLMaven Corp. (OTC Pink: SFLM), (“SFLMaven” or the “Company”) (www.sflmaven.com), a leading provider of high-end luxury goods, is excited to announce unaudited performance results for the week ended Thursday, June 2, 2022, which featured strong demand leading to $286k in total weekly sales.
The June 2 auction was highlighted by the sale of a heavy 18K...